N-Acetyl Semax vs PE-22-28 — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
N-Acetyl Semax is a modified form of Semax (the Russian-approved nootropic peptide based on ACTH(4-7)) with N-terminal acetylation added for improved enzymatic stability. The acetyl group protects against aminopeptidase degradation in nasal tissue, extending effective half-life a...
Calculate N-Acetyl Semax dose →PE-22-28 is a synthetic fragment of spadin (a naturally occurring peptide derived from the NTSR3/sortilin propeptide) that antagonizes TREK-1, a two-pore domain potassium channel (K2P channel) that regulates neuronal excitability. TREK-1 is strongly implicated in depression and c...
Calculate PE-22-28 dose →| Parameter | N-Acetyl Semax | PE-22-28 |
|---|---|---|
| Category | Cognitive & Neurological | Cognitive & Neurological |
| Research | Research Use | Preclinical |
| Half-Life | ~4–6 hours (extended vs. standard Semax) | - |
| Typical Dose | 100–400 µg | 100–200 µg |
| Frequency | Once or twice daily | Daily |
| Route | Intranasal | Subcutaneous / Intranasal |
| FDA Status | Not Approved | Not Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.